Health Secretary Robert F. Kennedy Jr. on Monday removed all 17 members of the expert panel that makes vaccine policy recommendations to the Centers for Disease Control and Prevention, saying they'd be replaced with "new members currently under consideration."
Why it matters: Health and Human Services portrayed the unprecedented move as "restoring public trust" in vaccines, but it's expected to introduce anti-vaccine ideology to the influential panel.
The trade group representing pharmacy benefit managers sued on Monday to overturn a first-in-the-nation state law that prevents them from owning pharmacies in Arkansas.
Why it matters: The Pharmaceutical Care Management Association's lawsuit adds to legal challenges to the ownership ban and comes as other states consider similar policies that blame large drug-price middlemen for rising pharmaceutical prices.
The top women in Senate and House Democratic leadership will host a forum this week on how women are affected by President Trump's "big, beautiful bill," Axios has learned.
Why it matters: Democrats argue the GOP's proposed cuts to programs like Medicaid and SNAP, and restrictions on reproductive health services, disproportionately affect women.
Animal welfare is becoming part of the Trump health team's agenda, as officials press for changes to drug approvals and product evaluations and portray lab animal testing as a symptom of big-government bloat.
Why it matters: The effort is the product of a more than decade-long push to elevate animal welfare issues with the political right that now features congressional oversight hearings and threats to cut off taxpayer funding.
